186 related articles for article (PubMed ID: 17635910)
1. Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains.
Cinar B; Mukhopadhyay NK; Meng G; Freeman MR
J Biol Chem; 2007 Oct; 282(40):29584-93. PubMed ID: 17635910
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol sensitivity of endogenous and myristoylated Akt.
Adam RM; Mukhopadhyay NK; Kim J; Di Vizio D; Cinar B; Boucher K; Solomon KR; Freeman MR
Cancer Res; 2007 Jul; 67(13):6238-46. PubMed ID: 17616681
[TBL] [Abstract][Full Text] [Related]
3. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.
Zhuang L; Kim J; Adam RM; Solomon KR; Freeman MR
J Clin Invest; 2005 Apr; 115(4):959-68. PubMed ID: 15776112
[TBL] [Abstract][Full Text] [Related]
5. Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.
Benitez DA; Pozo-Guisado E; Clementi M; Castellón E; Fernandez-Salguero PM
Br J Cancer; 2007 May; 96(10):1595-604. PubMed ID: 17486135
[TBL] [Abstract][Full Text] [Related]
6. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades.
Kim SM; Park JH; Kim KD; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS
Phytother Res; 2014 Mar; 28(3):423-31. PubMed ID: 23686889
[TBL] [Abstract][Full Text] [Related]
7. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling.
Arcaro A; Aubert M; Espinosa del Hierro ME; Khanzada UK; Angelidou S; Tetley TD; Bittermann AG; Frame MC; Seckl MJ
Cell Signal; 2007 May; 19(5):1081-92. PubMed ID: 17275257
[TBL] [Abstract][Full Text] [Related]
8. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src.
Sun M; Yang L; Feldman RI; Sun XM; Bhalla KN; Jove R; Nicosia SV; Cheng JQ
J Biol Chem; 2003 Oct; 278(44):42992-3000. PubMed ID: 12933816
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes.
Calay D; Vind-Kezunovic D; Frankart A; Lambert S; Poumay Y; Gniadecki R
J Invest Dermatol; 2010 Apr; 130(4):1136-45. PubMed ID: 20054340
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: a model of integration of genomic and non-genomic effects of the androgen receptor in cell lines model.
Bonaccorsi L; Nosi D; Quercioli F; Formigli L; Zecchi S; Maggi M; Forti G; Baldi E
Steroids; 2008 Oct; 73(9-10):1030-7. PubMed ID: 18358509
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cells.
Manin M; Baron S; Goossens K; Beaudoin C; Jean C; Veyssiere G; Verhoeven G; Morel L
Biochem J; 2002 Sep; 366(Pt 3):729-36. PubMed ID: 11971763
[TBL] [Abstract][Full Text] [Related]
12. Lipid raft cholesterol and genistein inhibit the cell viability of prostate cancer cells via the partial contribution of EGFR-Akt/p70S6k pathway and down-regulation of androgen receptor.
Oh HY; Leem J; Yoon SJ; Yoon S; Hong SJ
Biochem Biophys Res Commun; 2010 Mar; 393(2):319-24. PubMed ID: 20138837
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells.
Zhuang L; Lin J; Lu ML; Solomon KR; Freeman MR
Cancer Res; 2002 Apr; 62(8):2227-31. PubMed ID: 11956073
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells.
Baron S; Manin M; Beaudoin C; Leotoing L; Communal Y; Veyssiere G; Morel L
J Biol Chem; 2004 Apr; 279(15):14579-86. PubMed ID: 14668339
[TBL] [Abstract][Full Text] [Related]
15. Pterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor status.
Nikhil K; Sharan S; Chakraborty A; Roy P
PLoS One; 2014; 9(4):e93335. PubMed ID: 24699278
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor levels are upregulated by Akt in prostate cancer.
Ha S; Ruoff R; Kahoud N; Franke TF; Logan SK
Endocr Relat Cancer; 2011 Apr; 18(2):245-55. PubMed ID: 21317204
[TBL] [Abstract][Full Text] [Related]
17. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Oncogene; 2008 Jun; 27(28):3986-98. PubMed ID: 18332867
[TBL] [Abstract][Full Text] [Related]
18. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
[TBL] [Abstract][Full Text] [Related]
19. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.
Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S
Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
